Sara Marques

665 total citations
18 papers, 394 citations indexed

About

Sara Marques is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Marques has authored 18 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Marques's work include Congenital heart defects research (9 papers), Developmental Biology and Gene Regulation (7 papers) and Axon Guidance and Neuronal Signaling (3 papers). Sara Marques is often cited by papers focused on Congenital heart defects research (9 papers), Developmental Biology and Gene Regulation (7 papers) and Axon Guidance and Neuronal Signaling (3 papers). Sara Marques collaborates with scholars based in Portugal, Japan and United Kingdom. Sara Marques's co-authors include José António Belo, Cristina Borges, Ana Cristina Silva, Michelangelo Cordenonsi, Diego Echevarrı́a, José M. Inácio, Vera Teixeira, Salvador Martı́nez, Chikara Meno and Hiroshi Hamada and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and PLoS ONE.

In The Last Decade

Sara Marques

17 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Marques Portugal 11 352 92 30 30 29 18 394
Kemal O. Yariz United States 8 212 0.6× 90 1.0× 13 0.4× 24 0.8× 25 0.9× 9 346
Teresa Giugliano Italy 12 189 0.5× 94 1.0× 37 1.2× 31 1.0× 31 1.1× 21 339
Tiffany Busa France 11 174 0.5× 163 1.8× 16 0.5× 27 0.9× 44 1.5× 27 312
Christopher Stoddard United States 7 167 0.5× 91 1.0× 15 0.5× 41 1.4× 16 0.6× 11 258
Maria Luigia Cavaliere Italy 13 257 0.7× 171 1.9× 15 0.5× 36 1.2× 34 1.2× 19 372
Ryan Richholt United States 11 218 0.6× 54 0.6× 10 0.3× 44 1.5× 16 0.6× 16 335
Luis Rohena United States 12 192 0.5× 154 1.7× 24 0.8× 52 1.7× 39 1.3× 27 383
Mathilde Nizon France 13 239 0.7× 153 1.7× 17 0.6× 26 0.9× 28 1.0× 26 387
Amal Hashem Saudi Arabia 9 236 0.7× 138 1.5× 16 0.5× 54 1.8× 21 0.7× 11 354
Q. Tian Wang United States 10 427 1.2× 134 1.5× 15 0.5× 18 0.6× 19 0.7× 13 484

Countries citing papers authored by Sara Marques

Since Specialization
Citations

This map shows the geographic impact of Sara Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Marques more than expected).

Fields of papers citing papers by Sara Marques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Marques. The network helps show where Sara Marques may publish in the future.

Co-authorship network of co-authors of Sara Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Marques. A scholar is included among the top collaborators of Sara Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Marques. Sara Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Starling, Naureen, Bruce Colwell, John H. Strickler, et al.. (2024). AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon cancer.. Journal of Clinical Oncology. 42(3_suppl). TPS240–TPS240. 3 indexed citations
2.
Cohen, Jérémie F., Liang Wang, Sara Marques, et al.. (2022). Oocyte ERM and EWI Proteins Are Involved in Mouse Fertilization. Frontiers in Cell and Developmental Biology. 10. 863729–863729. 5 indexed citations
3.
Marques, Sara, et al.. (2022). STEMI-CR: Solution for Patients with Acute Myocardial Infarction at Home-Based Cardiac Rehabilitation Program. Procedia Computer Science. 196. 561–565.
4.
Inácio, José M., et al.. (2021). DAND5 Inactivation Enhances Cardiac Differentiation in Mouse Embryonic Stem Cells. Frontiers in Cell and Developmental Biology. 9. 629430–629430. 2 indexed citations
5.
Araújo, Inês, Filipa Marquês, Sara Marques, et al.. (2018). Diagnosis of sleep apnea in patients with stable chronic heart failure using a portable sleep test diagnostic device. Sleep And Breathing. 22(3). 749–755. 11 indexed citations
6.
Bonet, Fernando, et al.. (2018). CCBE1 is required for coronary vessel development and proper coronary artery stem formation in the mouse heart. Developmental Dynamics. 247(10). 1135–1145. 19 indexed citations
7.
Belo, José António, Sara Marques, & José M. Inácio. (2017). The Role of Cerl2 in the Establishment of Left-Right Asymmetries during Axis Formation and Heart Development. Journal of Cardiovascular Development and Disease. 4(4). 23–23. 12 indexed citations
9.
Marques, Sara, et al.. (2014). Targeted Inactivation of Cerberus Like-2 Leads to Left Ventricular Cardiac Hyperplasia and Systolic Dysfunction in the Mouse. PLoS ONE. 9(7). e102716–e102716. 15 indexed citations
10.
Inácio, José M., Sara Marques, Tetsuya Nakamura, et al.. (2013). The Dynamic Right-to-Left Translocation of Cerl2 Is Involved in the Regulation and Termination of Nodal Activity in the Mouse Node. PLoS ONE. 8(3). e60406–e60406. 27 indexed citations
11.
Marques, Sara, et al.. (2011). Identification and functional analysis of novel genes expressed in the Anterior Visceral Endoderm. The International Journal of Developmental Biology. 55(3). 281–295. 16 indexed citations
12.
Belo, José António, Ana Catarina Silva, Cristina Borges, et al.. (2009). Generating asymmetries in the early vertebrate embryo: the role of the Cerberus-like family. The International Journal of Developmental Biology. 53(8-9-10). 1399–1407. 24 indexed citations
13.
Oki, Shinya, Keiko Kitajima, Sara Marques, et al.. (2009). Reversal of left-right asymmetry induced by aberrant Nodal signaling in the node of mouse embryos. Development. 136(23). 3917–3925. 36 indexed citations
14.
Marques, Sara, et al.. (2004). The activity of the Nodal antagonist Cerl-2 in the mouse node is required for correct L/R body axis. Genes & Development. 18(19). 2342–2347. 143 indexed citations
15.
Echevarrı́a, Diego, Salvador Martı́nez, Sara Marques, Vera Teixeira, & José António Belo. (2004). Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer. Developmental Biology. 277(1). 114–128. 55 indexed citations
16.
Borges, Cristina, Sara Marques, & José António Belo. (2002). Goosecoid and cerberus-like do not interact during mouse embryogenesis.. PubMed. 46(2). 259–62. 6 indexed citations
17.
Borges, Cristina, Sara Marques, & José António Belo. (2001). The BMP antagonists cerberus-like and noggin do not interact during mouse forebrain development. The International Journal of Developmental Biology. 45(2). 441–444. 10 indexed citations
18.
Belo, José António, Daniel Bachiller, Eric Agius, et al.. (2000). Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. genesis. 26(4). 265–265. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026